PAMCX
Price
$92.69
Change
+$0.19 (+0.21%)
Updated
Jun 22 closing price
Net Assets
22.43B
TOECX
Price
$41.20
Change
+$0.34 (+0.83%)
Updated
Jun 22 closing price
Net Assets
2.19B
Interact to see
Advertisement

PAMCX vs TOECX

PAMCX vs TOECX Comparison Chart in %
View a ticker or compare two or three
VS
PAMCX vs. TOECX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAMCX is a Buy and TOECX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 22.4B vs. TOECX (2.19B). PAMCX (0.00) and TOECX (0.00) have matching dividends . PAMCX was incepted earlier than TOECX: PAMCX (26 years) vs TOECX (32 years). TOECX (2.05) is less costly to investors than PAMCX (1.02). TOECX is a more actively managed with annual turnover of: 79.00 vs. PAMCX (31.50). PAMCX (2500) and TOECX (2500) have matching initial minimum investment requirements. TOECX annual gain was more profitable for investors over the last year : 5.47 vs. PAMCX (-0.23). TOECX return over 5 years is better than : -15.68 vs. PAMCX (-21.57).
PAMCXTOECXPAMCX / TOECX
Total Expense Ratio1.022.0051%
Annual Report Gross Expense Ratio1.022.0550%
Fund Existence26 years32 years-
Gain YTD1.62613.31112%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets22.4B2.19B1,022%
Annual Yield % from dividends0.000.00-
Returns for 1 year-0.235.47-4%
Returns for 3 years0.1537.070%
Returns for 5 years-21.57-15.68138%
Returns for 10 years30.9620.26153%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IGTR36.400.44
+1.22%
Innovator Gradient Tactical Rot Str ETF
FTLS74.860.36
+0.48%
First Trust Long/Short Equity ETF
SJCP25.010.03
+0.12%
SanJac Alpha Core Plus Bond ETF
RCGE29.37N/A
N/A
RockCreek Global Equality ETF
PDN45.60-0.07
-0.16%
Invesco RAFI Developed Mkts ex-US S-METF